Abnormal lipoprotein metabolism in diabetic nephropathy.
Hirano T.
Clin Exp Nephrol. 2014 Apr;18(2):206-9. doi: 10.1007/s10157-013-0880-y. Epub 2013 Oct 17.
Lipoprotein abnormalities in diabetic nephropathy.
Hirano T.
Kidney Int Suppl. 1999 Jul;71:S22-4. doi: 10.1046/j.1523-1755.1999.07106.x.
Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.
Geng TT, Chen JX, Lu Q, Wang PL, Xia PF, Zhu K, Li Y, Guo KQ, Yang K, Liao YF, Zhou YF, Liu G, Pan A.
Am J Kidney Dis. 2024 Jan;83(1):9-17. doi: 10.1053/j.ajkd.2023.05.014. Epub 2023 Sep 9.
Normolipidemic lipoprotein glomerulopathy with IgA nephropathy - ApoE Kyoto mutation: a case report.
Yi X, Bai L, Chen K, He Y, Chen J.
Diagn Pathol. 2025 Apr 5;20(1):36. doi: 10.1186/s13000-025-01636-z.
Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.
Szymanski JM, Waldman M, Conry-Cantilena C, West KA.
J Clin Apher. 2019 Aug;34(4):495-498. doi: 10.1002/jca.21677. Epub 2018 Dec 10.
Lipoprotein metabolism and CKD: overview.
Barter P.
Clin Exp Nephrol. 2014 Apr;18(2):243-6. doi: 10.1007/s10157-013-0866-9. Epub 2013 Sep 20.
Apolipoprotein E-related glomerular disorders.
Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E.
Kidney Int. 2020 Feb;97(2):279-288. doi: 10.1016/j.kint.2019.10.031. Epub 2019 Nov 22.
Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Mackness M, Arrol S.
Atherosclerosis. 1991 Jul;89(1):49-57. doi: 10.1016/0021-9150(91)90006-o.
APOL1 Nephropathy Risk Variant Associations with Diseases beyond the Kidney: APOL1 and Sepsis.
Ma L, Freedman BI.
Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1684-1686. doi: 10.2215/CJN.10550919. Epub 2019 Nov 8.
APOL1 Nephropathy Risk Variants Through the Life Course: A Review.
Itoku A, Isaac J, Wilson S, Reidy K, Kaskel F.
Am J Kidney Dis. 2024 Jul;84(1):102-110. doi: 10.1053/j.ajkd.2023.12.014. Epub 2024 Feb 9.
